Ever wondered how a military veteran transitions to the civilian world, specifically the pharmaceutical construction industry? Meet Mark Blackbiller, an Army Ranger, 82nd Airborne, and Special Forces vet who's done just that. After bidding the military goodbye, Mark found himself navigating the uncharted territory of civilian life. His journey took him through hands-on construction jobs to the Director of Operations at PROTECS Inc. Listen in as he unravels his inspiring journey from the battlefield to the construction sites, and how he's using his military discipline to excel in the pharmaceutical construction industry. Mark's story is one of humility, patience, and the right attitude. He paints a vivid picture of the challenges he faced and the highs and lows in his transition process. Find out how Mark managed to turn his military service experience into an asset in the civilian world. Get inspired by his confidence and decision-making abilities that have made him invaluable in his chosen field. Mark's story serves as a beacon for other veterans who might be struggling with their transition. Listen as he shares his advice and insights into navigating the transition, and how vital attributes from the military can be transferred to find success in civilian life. The last leg of our talk dives into Mark's work in the pharmaceutical construction sector. He discusses the various facets of construction, from residential to pharmaceuticals, and how he's playing a crucial role in building facilities that potentially hold the cure to life-threatening diseases. If you're a veteran considering a career in the construction industry or someone interested in pharmaceutical construction, this episode is especially for you. Mark extends an open invitation to veterans seeking advice and guidance. So, gear up for an episode packed with insightful advice, powerful personal anecdotes, and a deep dive into the world of pharmaceutical construction. Don't miss out!
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More